ARHGEF9 and central nervous system cancer: Next, we designed a composite nomogram with REPIN1, PSD3, RDX, CDK4, FANCI, and ARHGEF9 to predict 1-, 3-, and 5-year OS in glioma patients (Figure 3(d)).